您的位置: 首页 > 农业专利 > 详情页

COMBINATION IL-2 IMMUNOCONJUGATE THERAPY
专利权人:
Roche Glycart AG
发明人:
Christian GERDES,Christian KLEIN,Valeria G. NICOLINI,Pablo UMANA
申请号:
US16807129
公开号:
US20200197492A1
申请日:
2020.03.02
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present invention provides combinations of (a) an immunoconjugate comprising a first antibody engineered to have reduced effector function and an effector moiety, and (b) a second antibody engineered to have increased effector function, for use in treating a disease in an individual in need thereof. Further provided are pharmaceutical compositions comprising the combinations, and methods of using them.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充